NCT03093155 2024-05-14
Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
Yale University
Phase 2 Completed
Clinical Trials
23 trialsNCT00630032 2024-02-21
TavIx
UNICANCER
Phase 3 Completed
NCT01446016 2023-01-23
CAT
The Methodist Hospital Research Institute
Phase 2 Completed
NCT00828308 2022-03-08
Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer
Brown University
Phase 2 Completed
NCT00741988 2021-12-15
Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00866905 2021-11-22
Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01097642 2021-09-22
ICE
The Methodist Hospital Research Institute
Phase 2 Completed
NCT00717704 2020-08-05
Solid Tumors Using Ixabepilone and Dasatinib
Medstar Health Research Institute
Phase 1 Completed
NCT01084057 2019-11-05
Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer
City of Hope Medical Center
Phase 1 Completed
NCT00096317 2018-10-31
Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors
Montefiore Medical Center
Phase 1 Completed
NCT00005807 2018-10-09
BMS-247550
Albert Einstein College of Medicine
Phase 1 Completed
NCT00030706 2018-09-28
Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
Montefiore Medical Center
Phase 2 Completed
NCT00627978 2018-06-26
Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons
Weill Medical College of Cornell University
Phase 2 Completed
NCT00789581 2017-07-02
TITAN
SCRI Development Innovations, LLC
Phase 3 Completed
NCT00637897 2017-05-30
Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer
Wake Forest University Health Sciences
Phase 1 Completed
NCT00884676 2015-10-09
Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors
University of Miami
Phase 1 Completed
NCT00821886 2014-12-22
Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00825734 2014-12-22
Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
SCRI Development Innovations, LLC
Phase 1/2 Completed
NCT00751868 2014-12-17
GIM9
Consorzio Oncotech
Phase 2 Completed
NCT00924352 2014-10-13
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Accelerated Community Oncology Research Network
Phase 1/2 Completed
NCT00022477 2013-09-05
BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
University of Chicago
Phase 2 Completed
NCT00017056 2013-06-18
BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00020904 2013-06-18
BMS-247550 in Treating Women With Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed